CONSERV BIOSCIENCE LIMITED
A89/100Summary
CONSERV BIOSCIENCE LIMITED is an active private limited company (company number 12930143) incorporated on 5 October 2020, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest micro accounts cover the period ending 31 December 2025, showing net assets of £243k, with 7 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 895% on the prior period (£24k). Across the last 3 periods on record the net-asset trend is rising.
By net assets it sits in the top quarter of 76 comparable companies in London (median £100, upper quartile £88k).
Key dates
- Incorporated
- 5 October 20206 yrs ago
- Next accounts due
- 30 September 2027in 343 days
- Confirmation statement due
- 19 October 2027in 362 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £243k | — | — | £27k | — | — | 7 |
| 31 December 2024 | £24k | £143k | £209k | — | — | — | 6 |
| 31 December 2023 | −£131k | £30k | £172k | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £243,385 at 2025-12-31 |
| +8 | Net assets growing+894.7% vs prior period |
| +8 | Comfortable liquidityCurrent ratio 7.3 |
| +5 | Multi-year filing history3 periods on record |
| +8 | EstablishedIncorporated 2020-10-05 (6 years) |
| 89 | Score, grade A |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
Ownership and control
- Peptcell Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Confirmation statement duein 362 days
- Next accounts duein 343 days
- Accounts period endNet assets £243k · micro accounts
- Accounts period endNet assets £24k · micro accounts
- Accounts period endNet liabilities £131k · micro accounts
- Incorporated
Similar companies in London
- STARK PHARMACEUTICALS LIMITEDLondon · inc. Aug 2020
- MAITRI ARTHA SHASTRA LIMITEDLondon · inc. Nov 2020
- SPACEPHARMA LIMITEDLondon · inc. Aug 2020
- BIONTECH UK LIMITEDLondon · inc. Nov 2020
- FENSTER CONSULTANTS LTDLondon · inc. Jul 2020
- MED X PHARMA TECH UK LIMITEDLondon · inc. Jul 2020
All companies incorporated on 5 October 2020 · in Oct 2020.
Reminders for CONSERV BIOSCIENCE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.